🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
MCK
NYSE
🇺🇸 US
McKesson Corporation
Healthcare
28Score
DipBuster Score™
$881.51
+$0.65 (+0.07%)
Live price · Source: Yahoo
52-Week Position
$687.68
62% of range
$999.00
Beta
0.307
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.307
52W High$999.00
52W Low$687.68
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (62% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position62% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.307
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at McKesson Corporation (MCK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-10 | Lerman Bradley E | SELL | 301 |
| 2026-08-07 | Srinivasan Ramesh (nmn) | BUY | 368 |
| 2026-07-22 | Hinton James H. | BUY | 277 |
| 2026-07-22 | Doughtie Lynne M | BUY | 277 |
| 2026-07-22 | Gerberding Julie L. | BUY | 277 |
| 2026-07-22 | Martinez Maria | BUY | 277 |
| 2026-07-22 | Lerman Bradley E | BUY | 277 |
| 2026-07-22 | Ozan Kevin M | BUY | 277 |
| 2026-07-22 | Caruso Dominic J | BUY | 277 |
| 2026-07-22 | Dunsire Deborah | BUY | 277 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.307
Dividend/yrNone
52W High$999.00
52W Low$687.68
52-Week Range
$687.68Now$999.00
62% through annual range
From 52W High−11.8%
From 52W Low+28.2%
📖 Plain English Summary
McKesson Corporation is at 62% of its 52-week range. Beta 0.307 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for MCK
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — MCK
Heuristic · balance sheet, insider filings, price data, academic research
McKesson Corporation — DipBuster Score 28/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track McKesson Corporation free
Add MCK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
15/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
4
/100 · NEUTRAL
dip depth
2/25
oversold rsi
0/25
mean reversion
1/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 28/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key busi…
Sector
Healthcare
Market
🇺🇸 US
CEO
Brian S. Tyler
Staff
42,300 employees
Website